Navigation Links
Last chance for media to pre-register for Europe's largest cancer congress: ECCO15-ESMO34
Date:9/11/2009

ECCO 15 ESMO 34 will take place at the ICC Berlin Internationales Congress Centrum, Messedamm 22, D-14055 Berlin, Germany (www.icc-berlin.de) from Sunday 20 September to Thursday 24 September 2009.

This is your last chance to pre-register to attend the congress. After Tuesday 15 September, you will have to register on-site in Berlin.

The first press conference will be held on Sunday 20 September at 16.00 hrs (CEST).

Registration

ECCO 15 ESMO 34 is open to bona fide representatives of print, electronic and broadcast media. For further details and media registration, go to: http://www.ecco-org.eu/Conferences-and-Events/ECCO-15-ESMO-34/page.aspx/216

NB: Media registration in advance is strongly recommended.

Press conferences and webcasts

There will be media news briefings at the following times:
Sunday 20 September, 16.00 hrs (CEST) in English (embargoed to Monday)
Monday 21 September, 11.00 hrs (CEST) in German
Tuesday 22 September, 11.15 hrs (CEST) in English
Wednesday 23 September, 11.15 hrs (CEST) in English

For journalists unable to attend the congress, all press conferences will be broadcast live by the open access journal ecancermedicalscience (http://www.ecancermedicalscience.com/), the ECCO15 ESMO34 official media partner. They will also be available to view on demand approximately one to two hours after the end each press conference.

Press conferences will be available to watch live to media only.

NB: you need to register in advance to watch the webcasts.

Register here in advance to access the daily webcasts: http://www.ecancermedicalscience.com/pressconference

If you have any questions regarding viewing the conferences please contact: jonathan@ecancermedicalscience.com

Here is a sample of the news results to be announced at the congress (embargoed to time of presentation at ECCO15-ESMO34):

  • New blood tests promise simple, cost-effective diagnosis of gastrointestinal cancers.
  • Can aspirin prevent cancer in people with an inherited predisposition to colon cancer? International clinical trial has the answer.
  • Surgical removal of primary tumour improves survival in metastatic breast cancer patients.
  • Genetic identification of patients who are hypersensitive to radiotherapy helps improve treatment and avoid side-effects.
  • Potentially practice-changing results of phase III trial combining targeted heat therapy with chemotherapy in locally advanced soft tissue sarcoma.
  • Largest and most comprehensive study to date investigates links between prostate cancer hormone therapy and heart disease.
  • Largest study to date investigates the effect of whole-brain radiotherapy in patients with limited spread of primary cancer to the brain.
  • Meta-analysis clarifying the impact of adding cetuximab to various chemotherapy combinations in advanced non-small cell lung cancer.
  • Expert calls for new cancer research priorities and outlines strategy to cope with growing burden of cases.
  • Significant advances made in treatment of malignant melanoma: two trials show improvements in overall survival and rapid shrinking of tumours.
  • New results from SOLTI randomised trial on use of sorafenib in combination with chemotherapy in advanced breast cancer.
  • Could HPV vaccination and screening eradicate cervical cancer?
  • New figures on the numbers of new cancers in Europe caused by excess body fat.
  • Pancreatic cancer: researchers find drug that reverses resistance to chemotherapy.
  • New research on ultrasound shows it can predict tumour burden and survival in melanoma patients, sparing unnecessary surgery.
  • Innovative test for new cancer drugs will lead to quicker validation and safer and more efficient clinical trials.
  • Keep taking the medicine: study of adjuvant endocrine treatment for breast cancer reveals the cost of patient non-compliance.
  • Switching early breast cancer patients to exemestane improves long-term survival.
  • Findings of the first study of teen experiences during the process of obtaining a cancer diagnosis.


'/>"/>

Contact: Emma Mason
wordmason@mac.com
44-771-129-6986
ECCO-the European CanCer Organisation
Source:Eurekalert

Related biology news :

1. Last chance for media to register for ECCO 14 -- the European Cancer Conference
2. Age increases chance of success as two-timer
3. UV light improving chances of fighting cancer
4. Research forecasts increased chances for stormy weather
5. TB bacterium uses its sugar coat to sweeten its chances of living in lungs
6. New CU-Boulder study shows diversity decreases chances of parasitic disease
7. Blood test predicts chance of dementia
8. Work of Field Museum scientist addresses question of chance in evolution
9. They are young and need the job: A second chance for dangerous T-cells
10. September Geology and GSA Today media highlights
11. Heart of Herschel to be presented to media
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)... 22, 2016   Acuant , the ... solutions, has partnered with RightCrowd ® ... Visitor Management, Self-Service Kiosks and Continuous Workforce ... add functional enhancements to existing physical access ... venues with an automated ID verification and ...
(Date:6/20/2016)... 20, 2016 Securus Technologies, a leading ... for public safety, investigation, corrections and monitoring announced ... it has secured the final acceptance by all ... Managed Access Systems (MAS) installed. Furthermore, Securus will ... be installed by October, 2016. MAS distinguishes between ...
(Date:6/9/2016)... June 9, 2016  Perkotek an innovation leader in attendance control systems is proud ... work hours, for employers to make sure the right employees are actually signing in, ... ... ... ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ... advised by its major shareholders, Clean Technology Fund I, ... United States based venture capital funds which ... Biorem (on a fully diluted, as converted basis), that ... of their entire equity holdings in Biorem to TUS ...
(Date:6/27/2016)... ... June 27, 2016 , ... Cancer experts ... they believe could be a new and helpful biomarker for malignant pleural mesothelioma. ... here to read it now. , Biomarkers are components in the blood, ...
(Date:6/27/2016)... ... 2016 , ... Newly created 4Sight Medical Solutions ... healthcare market. The company's primary focus is on new product introductions, to include ... are necessary to help companies efficiently bring their products to market. , The ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
Breaking Biology Technology: